Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Leqvio +114% cc Key Peptide Products: Lutathera (lutetium-177 DOTATATE, oncology peptide receptor radionuclide), Pluvicto (177Lu-PSMA-617), Sandostatin/Signifor (octreotide/pasireotide somatostatin analogues), Leqvio (inclisiran siRNA, category-adjacent) Therapeutic Segments: Oncology (radioligand therapy, CDK4/6 inhibitors)
Methodology: GSZ EPW
Aviso importante: no excedas la cantidad de consumo recomendada por un experto
Reasonable Incomplete Revascularization
US$ 20.95
US$ 26.56
.png?format=pjpeg&width=1600&quality=75&auto=webp)
US$ 28.70
US$ 21.14
US$ 21.07
US$ 28.79
US$ 26.16
US$ 24.17
